U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt

Merck

Market Cap: US$210.0b

Operates as a healthcare company worldwide.

Waters

Market Cap: US$17.5b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Agios Pharmaceuticals

Market Cap: US$2.3b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

CureVac

Market Cap: US$1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

SIGA Technologies

Market Cap: US$590.7m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Abeona Therapeutics

Market Cap: US$353.8m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

CytomX Therapeutics

Market Cap: US$341.4m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

Puma Biotechnology

Market Cap: US$256.9m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Coherus Oncology

Market Cap: US$132.5m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

Scinai Immunotherapeutics

Market Cap: US$1.4m

A biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel.